Activation of the Peroxisome Proliferator-Activated Receptors (PPAR-α/γ) and the Fatty Acid Metabolizing Enzyme Protein CPT1A by Camel Milk Treatment Counteracts the High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease

Angiotensin-I Converting Enzyme Inhibition and Antioxidant Activity of Papain-Hydrolyzed Camel Whey Protein and Its Hepato-Renal Protective Effects in Thioacetamide-Induced Toxicity

(2021) Ali Osman et al.   Foods

Pro‐inflammatory signalling and gut‐liver axis in non‐alcoholic and alcoholic steatohepatitis: Differences and similarities along the path

(2020) Trenton Glaser et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity

(2020) Marion Régnier et al.   Scientific Reports

TET1 promotes fatty acid oxidation and inhibits NAFLD progression by hydroxymethylation of PPARα promoter

(2020) Jingjie Wang et al.   Nutrition & Metabolism

Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease

(2020) Anne Fougerat et al.   Cells

Palmitoleic acid reduces high fat diet-induced liver inflammation by promoting PPAR-γ-independent M2a polarization of myeloid cells

(2020) Camila O. Souza et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa

(2020) Gamal Shiha et al.   Lancet Gastroenterology & Hepatology

Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet

(2019) Fan Zheng et al.   Lipids in Health and Disease

Camel milk insuline: Pathophysiological and molecular repository

(2019) Amjad Islam Aqib et al.   TRENDS IN FOOD SCIENCE & TECHNOLOGY

Attenuation of high-fat diet-induced fatty liver through PPARα activation by stevioside

(2019) Chang-Hao Jia et al.   Journal of Functional Foods

Adiponectin and PPAR: a setup for intricate crosstalk between obesity and non-alcoholic fatty liver disease

(2019) Syeda Momna Ishtiaq et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease

(2019) Ze Chen et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

PPAR Agonists and Metabolic Syndrome: An Established Role?

(2018) Margherita Botta et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice

(2018) Dongsheng Yu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Nonalcoholic fatty liver disease remission in men through regular exercise

(2018) Takafumi Osaka et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis

(2018) Jianye Dai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis

(2018) Zobair Younossi et al.   HEPATOLOGY

Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease

(2018) Xilin Li et al.   TOXICOLOGY

Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators

(2018) Domenica M. Corigliano et al.   PeerJ

Biomolecular content of camel milk: A traditional superfood towards future healthcare industry

(2017) Mohammadreza Khalesi et al.   TRENDS IN FOOD SCIENCE & TECHNOLOGY

Emerging Role of Adipocytokines in Type 2 Diabetes as Mediators of Insulin Resistance and Cardiovascular Disease

(2017) Ravindran Jaganathan et al.   Canadian Journal of Diabetes

Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease

(2016) Yaron Rotman et al.   GUT

Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD

(2016) Alexandra Montagner et al.   GUT

PPARγ signaling and emerging opportunities for improved therapeutics

(2016) Shuibang Wang et al.   PHARMACOLOGICAL RESEARCH

Adiponectin: a versatile player of innate immunity

(2016) Yan Luo et al.   Journal of Molecular Cell Biology

PPARs and Mitochondrial Metabolism: From NAFLD to HCC

(2016) Tommaso Mello et al.   PPAR Research

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

(2015) Eduardo Vilar-Gomez et al.   GASTROENTEROLOGY

PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis

(2015) Sven Francque et al.   JOURNAL OF HEPATOLOGY

Recent insights into the biological functions of liver fatty acid binding protein 1

(2015) GuQi Wang et al.   JOURNAL OF LIPID RESEARCH

Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine

(2015) Maria Lúcia Bonfleur et al.   LIFE SCIENCES

A structural perspective on nuclear receptors as targets of environmental compounds

(2014) Vanessa Delfosse et al.   ACTA PHARMACOLOGICA SINICA

Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets

(2014) Ffolliott M. Fisher et al.   GASTROENTEROLOGY

The Antidiabetic Action of Camel Milk in Experimental Type 2 Diabetes Mellitus: An Overview on the Changes in Incretin Hormones, Insulin Resistance, and Inflammatory Cytokines

(2014) A. Korish   HORMONE AND METABOLIC RESEARCH

Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease

(2014) Un Jung et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Camel milk inhibits inflammatory angiogenesis via downregulation of proangiogenic and proinflammatory cytokines in mice

(2013) Abdulqader A. Alhaider et al.   APMIS

Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease

(2013) Aida A Korish et al.   BMC Complementary and Alternative Medicine

Camel milk lactoferrin reduces the proliferation of colorectal cancer cells and exerts antioxidant and DNA damage inhibitory activities

(2013) Hosam M. Habib et al.   FOOD CHEMISTRY

Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

(2013) Bart Staels et al.   HEPATOLOGY

Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis

(2013) Jan Petrasek et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Camel Milk Triggers Apoptotic Signaling Pathways in Human Hepatoma HepG2 and Breast Cancer MCF7 Cell Lines through Transcriptional Mechanism

(2012) Hesham M. Korashy et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

PPARα Expression Protects Male Mice from High Fat–Induced Nonalcoholic Fatty Liver

(2011) Mohamed A. Abdelmegeed et al.   JOURNAL OF NUTRITION

Serum Levels of CK18 M30 and Leptin Are Useful Predictors of Steatohepatitis and Fibrosis in Paediatric NAFLD

(2010) Emer Fitzpatrick et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Anti-Inflammatory Effects of Fibrates: An Overview

(2009) Konstantinos Tziomalos et al.   CURRENT MEDICINAL CHEMISTRY

The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-  (PPAR ) and thiazolidinedione-PPAR  agonists

(2008) V Costa et al.   ENDOCRINE-RELATED CANCER